Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo E Mendes

Showing results (131-140 of 257) with videos related to

Pageof 26
Sort By:
Journal of Chemotherapy (Florence, Italy)|June 11, 2015
Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancinRodrigo E Mendes, Robert K Flamm, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|May 24, 2021
Characterization of a vga gene variant recovered from a Staphylococcus saprophyticus causing a community-acquired urinary tract infection: report from the SENTRY Antimicrobial Surveillance Program 2017Lalitagauri Deshpande, Laura Cantrell, José R Romero, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countriesMichael A Pfaller, Rodrigo E Mendes, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2016
Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014Michael A Pfaller, Robert K Flamm, Ronald N Jones, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2017
Antimicrobial Activity of Dalbavancin against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from U.S. Medical CentersHelio S Sader, Rodrigo E Mendes, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2012
The genetic environment of the cfr gene and the presence of other mechanisms account for the very high linezolid resistance of Staphylococcus epidermidis isolate 426-3147LJacqueline LaMarre, Rodrigo E Mendes, Teresa Szal, et al.
The Journal of Antimicrobial Chemotherapy|November 3, 2014
Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13)Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|August 21, 2016
Oritavancin in vitro activity against contemporary Staphylococcus aureus isolates responsible for invasive community- and healthcare-associated infections among patients in the United States (2013-2014)Leonard R Duncan, Helio S Sader, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|November 20, 2025
Post-pandemic trends in Streptococcus pneumoniae serotype epidemiology and antibiotic susceptibility in adults with invasive and non-invasive pneumococcal disease in the USA (2022-2023)Mekki F Bensaci, Karri A Bauer, Kenneth Klinker, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2012
Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalisLorena Diaz, Pattarachai Kiratisin, Rodrigo E Mendes, et al.
Pageof 26

Showing results (131-140 of 257) with videos related to

Sort By:
Pageof 26
Journal of Chemotherapy (Florence, Italy)|June 11, 2015
Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancinRodrigo E Mendes, Robert K Flamm, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|May 24, 2021
Characterization of a vga gene variant recovered from a Staphylococcus saprophyticus causing a community-acquired urinary tract infection: report from the SENTRY Antimicrobial Surveillance Program 2017Lalitagauri Deshpande, Laura Cantrell, José R Romero, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countriesMichael A Pfaller, Rodrigo E Mendes, Jennifer M Streit, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2016
Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014Michael A Pfaller, Robert K Flamm, Ronald N Jones, et al.
Antimicrobial Agents and Chemotherapy|December 22, 2017
Antimicrobial Activity of Dalbavancin against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from U.S. Medical CentersHelio S Sader, Rodrigo E Mendes, Leonard R Duncan, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2012
The genetic environment of the cfr gene and the presence of other mechanisms account for the very high linezolid resistance of Staphylococcus epidermidis isolate 426-3147LJacqueline LaMarre, Rodrigo E Mendes, Teresa Szal, et al.
The Journal of Antimicrobial Chemotherapy|November 3, 2014
Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13)Rodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|August 21, 2016
Oritavancin in vitro activity against contemporary Staphylococcus aureus isolates responsible for invasive community- and healthcare-associated infections among patients in the United States (2013-2014)Leonard R Duncan, Helio S Sader, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|November 20, 2025
Post-pandemic trends in Streptococcus pneumoniae serotype epidemiology and antibiotic susceptibility in adults with invasive and non-invasive pneumococcal disease in the USA (2022-2023)Mekki F Bensaci, Karri A Bauer, Kenneth Klinker, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2012
Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalisLorena Diaz, Pattarachai Kiratisin, Rodrigo E Mendes, et al.
Pageof 26